CRBG
Corebridge Financial, Inc.
CRBG has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
CRBG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
CRBG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CRBG.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CRBG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.7x | $35.97 | — |
| Cheap | 7.4x | $33.58 | -6.6% |
| Current | 8x | $35.97 | — |
| Fair | 9.6x | $43.16 | +20% |
| Expensive | 29x | $130 | +262% |
Historical ranges are pointers, not guarantees.
CRBG has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
CRBG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CRBG's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CRBG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.39 | +19% |
| Q3 2026 | $4.51 | +178% |
| Q2 2026 | $1.56 | +$2.23 |
| Q1 2026 | $0.40 | -64% |
| Q4 2025 | -$0.68 | -118% |
| Q3 2025 | $1.62 | +$3.69 |
| Q2 2025 | -$0.67 | -121% |
| Q1 2025 | $1.12 | -71% |
| Q4 2024 | $3.72 | +118% |
CRBG earned $4.51 per share over the past year, up 178% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over CRBG on earnings, with more consistent year-over-year improvement.
CRBG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.2B | +14% |
| Q2 2026 | $3.9B | +43% |
| Q1 2026 | $4B | +10% |
| Q4 2025 | $6.8B | +2.2% |
| Q3 2025 | $5.4B | +107% |
| Q2 2025 | $2.7B | -26% |
| Q1 2025 | $3.6B | -38% |
| Q4 2024 | $6.6B | +97% |
CRBG's revenue has grown year over year for five quarters in a row: $6.2B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | +39 points |
| Q2 2026 | 1.3% | +24 points |
| Q1 2026 | 2.5% | +27 points |
| Q4 2025 | 14% | -30 points |
| Q3 2025 | -0.8% | +60 points |
| Q2 2025 | -22% | -35 points |
| Q1 2025 | -24% | -41 points |
| Q4 2024 | 44% | +97 points |
CRBG's operating margin was 38% last quarter, up 38 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over CRBG on profitability, with a higher operating margin.
CRBG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $605M | +2421% |
| Q2 2026 | -$44M | +$215M |
| Q1 2026 | -$9M | -102% |
| Q4 2025 | $1.9B | +27% |
| Q3 2025 | $24M | -71% |
| Q2 2025 | -$259M | -$250M |
| Q1 2025 | $375M | -37% |
| Q4 2024 | $1.5B | +93% |
CRBG has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CRBG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -7M shares |
| 1 year | -17% | -93.4M shares |
| 3 years | -30% | -194M shares |
CRBG has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $185M |
| Q2 2026 | $300M |
| Q1 2026 | $1.3B |
| Q4 2025 | $1.1B |
| Q3 2025 | $380M |
| Q2 2025 | $311M |
| Q1 2025 | $321M |
| Q4 2024 | $398M |
CRBG spent $2.8B buying back its own shares over the past year, up 101% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CRBG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | 360.7x | High |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 1.9x | Healthy |
CRBG has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CRBG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.8 | Neutral |
| Stochastic | 72.5 | Neutral |
CRBG's weekly RSI is 66 (neutral) and its Stochastic is 73 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CRBG PE vs Financial Services Sector
| Metric | CRBG | Sector median | Relative |
|---|---|---|---|
| PE | 8x | 13x | 39% below |
| PE % | 29 | 57 | 28 pts below |
CRBG has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
CRBG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.6 | 4.1% above |
| 20 week MA | $33.4 | 7.7% above |
| 50 week MA | $30.2 | 19% above |
| 100 week MA | $31.1 | 16% above |
| 200 week MA | $27.3 | 32% above |
CRBG has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
CRBG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $20.7 | $20.3 | -2.2% |
| 2023 | $20.3 | $21.7 | +6.9% |
| 2024 | $21.7 | $30.0 | +39% |
| 2025 | $30.0 | $30.6 | +1.9% |
| 2026 YTD | $30.6 | $36.0 | +18% |
CRBG has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.